Riding the Employment Roller Coaster - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Riding the Employment Roller Coaster
2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.


Pharmaceutical Technology
Volume 34, Issue 12, pp. 36-39

Salary and satisfaction


Figure 6: Company expansion plans by location.
If you didn't lose your job, 2010 was a good year. Overall salaries increased 8.9% to $102,468. Men earned more than women: $103,787.55 for men versus an average of $100,469.01 for women. The average industry salary in the US was the highest—$ 113,343, followed by $81,076 in Canada; $74,049 in Western Europe; and $58,833 in India. A full 100% of Indian workers report receiving salary increases this year, followed by 69.2% in Canada, and 65.4% in the US. Least likely to have received a raise this past year were Western Europeans, with only 49.3% reporting salary increases. Canadians were most likely to receive salary cuts—with 7.7% of Canadian respondents reporting decreases, followed by 7.4% of US respondents, and 5.85% of Western Europeans.


Figure 7: Job selection factors-most important (multiple responses allowed).
In general, people working in the pharmaceutical industry feel gratified and valued by their employers—64.6% of all respondents said their employers fully valued their work. Employees of generic-drug manufacturing firms feel most valued, 68.9% reported feeling valued, followed by 67.1% of workers in traditional bio/pharmaceutical companies who feel that way. Least valued are workers for contract manufacturers and service providers, where 58.4% feel valued. On average men feel slightly more valued than do women, as 65.2% of men, and 62.4% of women reported feeling their work was valued.


Figure 8: Effect of economy on job (multiple responses allowed).
The feeling may not be entirely mutual, however. Over half—58.5% of respondents from contract manufacturer and service providers—say they would leave their jobs if they could. Almost the same number (58.3%) from biotech companies say they'd leave their companies if they could. Employees at traditional bioo/pharmaceutical companies are least likely to look for new jobs, since only 41.2% say they'd switch jobs if they could.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
43%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
14%
Raw material supply problems
14%
Regulatory restrictions
0%
Business decisions to limit production
29%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here